Top

previous article Altered Mortality: Why the Quest for Immortalit...

next article Hype, Hope, and Help: Situating a Science Annou...

Hint

Swipe to navigate through the articles of this issue

22-11-2019 | Discussion Note | Issue 3/2019

What Counts as “Success” in Speculative and Anticipatory Ethics? Lessons from the Advent of Germline Gene Editing

Journal:: NanoEthics > Issue 3/2019

Author:: Ari Schick

» Get access to the full-text

Important notes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abstract

This discussion note offers a preliminary analysis of what recent developments in human germline gene editing tell us about the effectiveness of speculative and anticipatory modes of techno-ethics. It argues that the benefits of speculative discussions are difficult to detect thus far, and that pushing the focal point of ethical discourse well ahead of the current state of technology may prematurely undermine existing norms long before a broad consensus would justify moving beyond them.

Please log in to get access to this content

To get access to this content you need the following product:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 69.000 Bücher
über 500 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Umwelt
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Testen Sie jetzt 30 Tage kostenlos.

inform now

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 58.000 Bücher
über 300 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Testen Sie jetzt 30 Tage kostenlos.

inform now

Weckert J (2007) Editorial. NanoEthics 1(1):1–2. https://doi.org/10.1007/s11569-007-0009-4 CrossRef

Nordmann A (2007) If and then: a critique of speculative nanoethics. NanoEthics. 1(1):31–46. https://doi.org/10.1007/s11569-007-0007-6 CrossRef

Collingridge D (1980) The social control of technology. St. Martin’s Press, New York

Agar N (2004) Liberal eugenics: in defence of human enhancement. Blackwell, Malden CrossRef

Schick A (2017) Bioethics and the regulation/legitimation of the imagined future. In: Verschraegen G, Vandermoere F, BraeckmansL, Segaert B (eds.) Imagined futures in science, technology and society. Routledge, London, Ch. 2

Walters L (2012) Genetics and bioethics: how our thinking has changed since 1969. Theor Med Bioeth. 33(1):83–95. https://doi.org/10.1007/s11017-012-9210-8 CrossRef

President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research (1982). Splicing life: a report on the social and ethical issues of genetic engineering with human beings. Washington, DC

Juengst ET (1991) The human genome project and bioethics. Kennedy Inst Ethics J. 1(1):71–74 CrossRef

Walters L (1991) Human gene therapy: ethics and public policy. Hum Gene Ther. 2(2):115–122 CrossRef

10.

Juengst ET (1991) Germ-line gene therapy: back to basics. J Med Philos. 16(6):587–592 CrossRef

11.

Parens E (2000) Enhancing human traits: ethical and social implications. Georgetown University Press, Washington, DC

12.

Lenzi RN, Altevogt BM, Gostin LO (2014) Oversight and review of clinical gene transfer protocols: assessing the role of the recombinant DNA advisory committee. The National Academies Press, Washington, DC

13.

Baltimore D, Berg P, Botchan M et al (2015) A prudent path forward for genomic engineering and germline gene modification. Science. 348(6230):36–38. https://doi.org/10.1126/science.aab1028 CrossRef

14.

Liang P, Xu Y, Zhang X, Ding C, Huang R, Zhang Z, Lv J, Xie X, Chen Y, Li Y, Sun Y, Bai Y, Songyang Z, Ma W, Zhou C, Huang J (2015) CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell. 6(5):363–372. https://doi.org/10.1007/s13238-015-0153-5 CrossRef

15.

Organizing Committee for the International Summit on Human Gene Editing (2015) On human gene editing: international summit statement.. http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=12032015a. Accessed 17 Jan 2019

16.

National Academy of Sciences, National Academy of Medicine Committee on Human Gene Editing (2017) Human genome editing: science, ethics, and governance. National Academies Press, Washington, D.C. https://doi.org/10.17226/24623

17.

Kaiser J. U.S. panel gives yellow light to human embryo editing. Science. http://www.sciencemag.org/news/2017/02/us-panel-gives-yellow-light-human-embryo-editing. Accessed 29 Jan 2019

18.

Juengst ET (2017) Crowdsourcing the moral limits of human gene editing? Hastings Cent Rep. 47(3):15–23. https://doi.org/10.1002/hast.701 CrossRef

19.

Evans JH (2012) The history and future of bioethics: a sociological view. Oxford University Press, New York

20.

HFEA approval for new genome editing techniques. Francis Crick Institute. https://www.crick.ac.uk/news/2016-02-01-hfea-decision. Accessed 24 Jan 2019

21.

Servick K. First U.S. team to gene-edit human embryos revealed. Science. http://www.sciencemag.org/news/2017/07/first-us-team-gene-edit-human-embryos-revealed. Accessed 24 Jan 2019

22.

Regalado A. Years before CRISPR babies, this man was the first to edit human embryos. MIT Technology Review. https://www.technologyreview.com/s/612554/years-before-crispr-babies-this-man-was-the-first-to-edit-human-embryos/. Accessed 17 Jan 2019

23.

Belluck P. How to stop rogue gene-editing of human embryos? The New York Times. https://www.nytimes.com/2019/01/23/health/gene-editing-babies-crispr.html. Accessed 24 Jan 2019

24.

Greely H. Of Science, CRISPR-Cas9, and Asilomar. Law Biosci Blog. April 2015. https://law.stanford.edu/2015/04/04/of-science-crispr-cas9-and-asilomar/. Accessed 29 Feb 2016

25.

Evans JH (2002) Playing God? Human genetic engineering and the rationalization of public bioethical debate. University of Chicago Press, Chicago

26.

Juengst ET (2000) What does enhancement mean? In: Parens E (ed) Enhancing human traits. Georgetown University Press, Washington, DC, pp 29–47

27.

Jasanoff S, Hurlbut JB (2018) A global observatory for gene editing. Nature. 555(7697):435. https://doi.org/10.1038/d41586-018-03270-w CrossRef

28.

Next time, ask first: The affair of the gene-edited babies rumbles on. The Economist. 429(9122):82–83. https://www.economist.com/science-and-technology/2018/12/15/the-affair-of-the-gene-edited-babies-rumbles-on. Accessed 24 Jan 2019

29.

Schick A (2014) Lessons for the future? Prophecy and policy in speculative bioethics. Michigan State University

Title: What Counts as “Success” in Speculative and Anticipatory Ethics? Lessons from the Advent of Germline Gene Editing
Author:: Ari Schick
Publication date: 22-11-2019
DOI: https://doi.org/10.1007/s11569-019-00350-7
Publisher: Springer Netherlands
Journal: NanoEthics Studies of New and Emerging Technologies
Issue 3/2019
Print ISSN: 1871-4757
Electronic ISSN: 1871-4765

Premium Partner

Image Credits

Springer Professional

Hint

Swipe to navigate through the articles of this issue

Publisher’s Note

Abstract

Please log in to get access to this content

To get access to this content you need the following product:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Wirtschaft"

Other articles of this Issue 3/2019

Editing the Gene Editing Debate: Reassessing the Normative Discussions on Emerging Genetic Technologies

Hype, Hope, and Help: Situating a Science Announcement in a Web of Stories

From Asilomar to Genome Editing: Research Ethics and Models of Decision

‘Eugenics is Back’? Historic References in Current Discussions of Germline Gene Editing

Altered Mortality: Why the Quest for Immortality is Regaining Visibility in the Media

Chinese Public and Nanoresearchers’ Perceptions of Benefits and Risks of Nanotechnology

Premium Partner